Report Detail
Global Nontuberculous Mycobacterium Treatment Market Growth (Status and Outlook) 2022-2028
- RnM4385499 |
- 18 February, 2022 |
- Global |
- 85 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Nontuberculous Mycobacterium Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Nontuberculous Mycobacterium Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nontuberculous Mycobacterium Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Nontuberculous Mycobacterium Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nontuberculous Mycobacterium Treatment market, reaching US$ million by the year 2028. As for the Europe Nontuberculous Mycobacterium Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Nontuberculous Mycobacterium Treatment players cover Insmed Incorporated, RedHill Biopharma, Novoteris, and Savara, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nontuberculous Mycobacterium Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Azithromycin
Rifampin
Rifabutin
Ethambuto
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals Pharmacies
Private clinics
Drug Stores and Retail Pharmacy
E-commerce
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Insmed Incorporated
RedHill Biopharma
Novoteris
Savara
Beyond Air
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nontuberculous Mycobacterium Treatment Market Size 2017-2028
- 2.1.2 Nontuberculous Mycobacterium Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Nontuberculous Mycobacterium Treatment Segment by Type
- 2.2.1 Azithromycin
- 2.2.2 Rifampin
- 2.2.3 Rifabutin
- 2.2.4 Ethambuto
- 2.3 Nontuberculous Mycobacterium Treatment Market Size by Type
- 2.3.1 Nontuberculous Mycobacterium Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Nontuberculous Mycobacterium Treatment Market Size Market Share by Type (2017-2022)
- 2.4 Nontuberculous Mycobacterium Treatment Segment by Application
- 2.4.1 Hospitals Pharmacies
- 2.4.2 Private clinics
- 2.4.3 Drug Stores and Retail Pharmacy
- 2.4.4 E-commerce
- 2.5 Nontuberculous Mycobacterium Treatment Market Size by Application
- 2.5.1 Nontuberculous Mycobacterium Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Nontuberculous Mycobacterium Treatment Market Size Market Share by Application (2017-2022)
3 Nontuberculous Mycobacterium Treatment Market Size by Player
- 3.1 Nontuberculous Mycobacterium Treatment Market Size Market Share by Players
- 3.1.1 Global Nontuberculous Mycobacterium Treatment Revenue by Players (2020-2022)
- 3.1.2 Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Players (2020-2022)
- 3.2 Global Nontuberculous Mycobacterium Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Nontuberculous Mycobacterium Treatment by Regions
- 4.1 Nontuberculous Mycobacterium Treatment Market Size by Regions (2017-2022)
- 4.2 Americas Nontuberculous Mycobacterium Treatment Market Size Growth (2017-2022)
- 4.3 APAC Nontuberculous Mycobacterium Treatment Market Size Growth (2017-2022)
- 4.4 Europe Nontuberculous Mycobacterium Treatment Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Nontuberculous Mycobacterium Treatment Market Size by Country (2017-2022)
- 5.2 Americas Nontuberculous Mycobacterium Treatment Market Size by Type (2017-2022)
- 5.3 Americas Nontuberculous Mycobacterium Treatment Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Nontuberculous Mycobacterium Treatment Market Size by Region (2017-2022)
- 6.2 APAC Nontuberculous Mycobacterium Treatment Market Size by Type (2017-2022)
- 6.3 APAC Nontuberculous Mycobacterium Treatment Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Nontuberculous Mycobacterium Treatment by Country (2017-2022)
- 7.2 Europe Nontuberculous Mycobacterium Treatment Market Size by Type (2017-2022)
- 7.3 Europe Nontuberculous Mycobacterium Treatment Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Nontuberculous Mycobacterium Treatment by Region (2017-2022)
- 8.2 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Nontuberculous Mycobacterium Treatment Market Forecast
- 10.1 Global Nontuberculous Mycobacterium Treatment Forecast by Regions (2023-2028)
- 10.1.1 Global Nontuberculous Mycobacterium Treatment Forecast by Regions (2023-2028)
- 10.1.2 Americas Nontuberculous Mycobacterium Treatment Forecast
- 10.1.3 APAC Nontuberculous Mycobacterium Treatment Forecast
- 10.1.4 Europe Nontuberculous Mycobacterium Treatment Forecast
- 10.1.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Forecast
- 10.2 Americas Nontuberculous Mycobacterium Treatment Forecast by Country (2023-2028)
- 10.2.1 United States Nontuberculous Mycobacterium Treatment Market Forecast
- 10.2.2 Canada Nontuberculous Mycobacterium Treatment Market Forecast
- 10.2.3 Mexico Nontuberculous Mycobacterium Treatment Market Forecast
- 10.2.4 Brazil Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3 APAC Nontuberculous Mycobacterium Treatment Forecast by Region (2023-2028)
- 10.3.1 China Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.2 Japan Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.3 Korea Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.4 Southeast Asia Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.5 India Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.6 Australia Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4 Europe Nontuberculous Mycobacterium Treatment Forecast by Country (2023-2028)
- 10.4.1 Germany Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.2 France Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.3 UK Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.4 Italy Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.5 Russia Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Forecast by Region (2023-2028)
- 10.5.1 Egypt Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.2 South Africa Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.3 Israel Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.4 Turkey Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.5 GCC Countries Nontuberculous Mycobacterium Treatment Market Forecast
- 10.6 Global Nontuberculous Mycobacterium Treatment Forecast by Type (2023-2028)
- 10.7 Global Nontuberculous Mycobacterium Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Insmed Incorporated
- 11.1.1 Insmed Incorporated Company Information
- 11.1.2 Insmed Incorporated Nontuberculous Mycobacterium Treatment Product Offered
- 11.1.3 Insmed Incorporated Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Insmed Incorporated Main Business Overview
- 11.1.5 Insmed Incorporated Latest Developments
- 11.2 RedHill Biopharma
- 11.2.1 RedHill Biopharma Company Information
- 11.2.2 RedHill Biopharma Nontuberculous Mycobacterium Treatment Product Offered
- 11.2.3 RedHill Biopharma Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 RedHill Biopharma Main Business Overview
- 11.2.5 RedHill Biopharma Latest Developments
- 11.3 Novoteris
- 11.3.1 Novoteris Company Information
- 11.3.2 Novoteris Nontuberculous Mycobacterium Treatment Product Offered
- 11.3.3 Novoteris Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Novoteris Main Business Overview
- 11.3.5 Novoteris Latest Developments
- 11.4 Savara
- 11.4.1 Savara Company Information
- 11.4.2 Savara Nontuberculous Mycobacterium Treatment Product Offered
- 11.4.3 Savara Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Savara Main Business Overview
- 11.4.5 Savara Latest Developments
- 11.5 Beyond Air
- 11.5.1 Beyond Air Company Information
- 11.5.2 Beyond Air Nontuberculous Mycobacterium Treatment Product Offered
- 11.5.3 Beyond Air Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Beyond Air Main Business Overview
- 11.5.5 Beyond Air Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nontuberculous Mycobacterium Treatment. Industry analysis & Market Report on Nontuberculous Mycobacterium Treatment is a syndicated market report, published as Global Nontuberculous Mycobacterium Treatment Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nontuberculous Mycobacterium Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
